The head of Iranian Privatization Organization announced divesting the shares of 370 companies with the volume of 700,000 billion Rials during the past 5 years in the country. He mentioned "in addition to the divesting pathology, monitoring will be done not only during the divesting, but also after it."

In an interview with Mehr News Agency, about the control after divesting, Dr. Peyman Noori adds "one of the priority matters is subject pathology."

Referring divesting the shares of 370 companies with the volume of 700,000 billion Rials during the past 5 years until now, head of IPO stated: "this figure is considerably high; meanwhile it is subsequently important for us even one or two companies are torment with problems.

He announced the pathology in these cases to be the base of function in the next divesting and reiterated: "the controls are in two forms; during the divesting controls and after divesting ones."

Dr. Noori added: "the way of supervision from board meeting, balance sheets, being present in the companies board meeting could result in the right execution of principle 44 and the goal of this principle; in fact the result of privatization is more important than the quantity of divesting.

Deputy Minister of Economic affairs & Finance further noted: "the emphasis is on doing all the agenda together at the same time. For the purpose of empowering the private sector, one ought to inform and cultural building must be accomplished."  

Noori expressed: "interaction with banking and monetary institutions is very important to support these divested firms. It should have been paid attention to the variety in the ways of supply and divesting the shares and facilitate the entering of foreign investment into the country."

The head of IPO mentioned the concerns reduction of the private sector and elimination of the cumbersome regulations to empowering the private sector and then highlighted: "if it is needed to reform the law, we will do it accompany with the Majlis (Parliament)".